The use of antidepressants to treat depression in children and adolescents
Canadian Medical Association JournalPublished 16 January 2006Open access
Anthony H. Cheung
Citations70
SJR quartileQ1
SJR score0.92
SNIP1.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The current state of research into antidepressant therapy for major depression in children and adolescents is reviewed and methodologic issues and clinical implications specific to the pediatric population are discussed.
Abstract
The dramatic increase over the past 10 years in the amount of available clinical research on the use of antidepressants to treat major depression in children and adolescents has substantially improved our knowledge of the safety and efficacy of these medications in the pediatric population. Many questions remain, however, that highlight the need to continue research in this patient population rather than relying on the extrapolation of data from trials involving adults. In this article, we review the current state of research into antidepressant therapy for major depression in children and adolescents. In addition, we discuss methodologic issues and clinical implications specific to the pediatric population.
Keywords
PsychologySocial SciencesMedicine
Journal of the American Academy of Child & Adolescent PsychiatryChildhood and Adolescent Depression: A Review of the Past 10 Years. Part I
2,091 Citations1996Boris Birmaher, Neal D. Ryan +6 more
JAMAFluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression
1,739 Citations2004John S. March, Susan G. Silva +9 more
The combination of fluoxetine with CBT offered the most favorable tradeoff between benefit and risk for adolescents with major depressive disorder.
Archives of General PsychiatryA Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With Depression
998 Citations1997Graham J. Emslie
Fluoxetine was superior to placebo in the acute phase treatment of major depressive disorder in child and adolescent outpatients with severe, persistent depression, and complete remission of symptoms was rare.
JAMADepressed Adolescents Grown Up
972 Citations1999Myrna M. Weissman
There is substantial continuity, specificity, morbidity, and potential mortality from suicide into adulthood in adolescent-onset MDD patients.
Archives of General PsychiatryAdult Outcomes of Childhood and Adolescent Depression
769 Citations1990R.W. Harrington
There is substantial specificity in the continuity of affective disturbances between childhood and adult life, and the depressed group was at an increased risk for affective disorder in adult life and had elevated risks of psychiatric hospitalization and psychiatric treatment.
Archives of General PsychiatryDepressive Disorders in Childhood
704 Citations1984Mária Kovács
The characteristics and diagnostic validity of major depressive disorder, dysthymic disorder, and adjustment disorder with depressed mood were examined in a school-aged cohort and early age at onset predicted a more protracted illness.
Archives of General PsychiatryAdult Sequelae of Adolescent Depressive Symptoms
649 Citations1986Denise B. Kandel
Depressive mood seems to be associated with a deficiency to establish close interpersonal relationships within the family that expresses itself differently at different stages of the life cycle: toward parents in adolescence, and toward spouses and parents in young adulthood.
Journal of the American Academy of Child & Adolescent PsychiatryEfficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
648 Citations2001Martin B. Keller, Neal D. Ryan +20 more
Paroxetine demonstrated significantly greater improvement compared with placebo in Hamilton Rating Scale for Depression total score < or = 8, HAM-D depressed mood item, K-SADS-L depressed Mood item, and CGI score of 1 or 2.
Journal of the American Academy of Child & Adolescent PsychiatryFluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial
574 Citations2002Graham J. Emslie, John H. Heiligenstein +6 more
Fluoxetine 20 mg daily appears to be well tolerated and effective for acute treatment of MDD in child and adolescent outpatients.
Journal of the American Academy of Child & Adolescent PsychiatryUnipolar Depression in Adolescents: Clinical Outcome in Adulthood
522 Citations1995Uma Rao, Neal D. Ryan +6 more
Adolescent unipolar MDD predicts continued risk for recurrences with persistence of depressive episodes and psychosocial morbidity into adulthood as well as sustained periods of remission associated with good social adjustment.
Archives of General PsychiatryDepressive Disorders in Childhood
505 Citations1984Mária Kovács
As part of a longitudinal nosologic study of major depressive disorder, dysthymic disorder (DD), and adjustment disorder with depressed mood (ADDM) in a school-aged cohort, the predictive validity of each diagnosis was examined.
Archives of General PsychiatryRelationship Between Antidepressant Medication Treatment and Suicide in Adolescents
433 Citations2003Mark Olfson, David Shaffer +2 more
An inverse relationship between regional change in use of antidepressants and suicide raises the possibility of a role for using antidepressant treatment in youth suicide prevention efforts, especially for males, older adolescents, and adolescents who reside in lower-income regions.
JAMAEfficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder<SUBTITLE>Two Randomized Controlled Trials</SUBTITLE>
415 Citations2003Karen Dineen Wagner
The results of this pooled analysis demonstrate that sertraline is an effective and well-tolerated short-term treatment for children and adolescents with MDD.
Journal of the American Academy of Child & Adolescent PsychiatryPredictors of Treatment Efficacy in a Clinical Trial of Three Psychosocial Treatments for Adolescent Depression
377 Citations1998David A. Brent, David J. Kolko +5 more
Predictors of poor outcome may give clues as to how to boost treatment response, and CBT is likely to be a robust intervention even in more complex and difficult-to-treat patients.
Acta Psychiatrica ScandinavicaSuicide prevention — a medical breakthrough?
351 Citations2000Göran Isacsson
The author hypothesized, based on research until 1991, that a five‐fold increase in the use of antidepressants might reduce Swedish suicide rates by 25% and a subsequent 3.5‐fold rise provided a ‘natural experimental situation’ for prospectively testing this hypothesis.
Journal of the American Academy of Child & Adolescent PsychiatryDepression in Young People: Initial Presentation and Clinical Course
350 Citations1993Elizabeth McCauley, KATHLEEN MYERS +4 more
Depressed youths who completed the 3-year follow-up confirmed depression in youth as a valid clinical phenomenon, with substantial risk of recurrence, and increased levels of stress in the family environment were associated with poorer overall outcomes.
BMJAssociation between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
318 Citations2003Wayne Hall
Changes in suicide rates and exposure to antidepressants in Australia for 1991-2000 are significantly associated, and the rate of suicide fell in older people, the age group most heavily exposed to antidepressants.
American Journal of PsychiatryA Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents
310 Citations2004Karen Dineen Wagner, Adelaide S. Robb +4 more
Cochrane Database of Systematic ReviewsTricyclic drugs for depression in children and adolescents
288 Citations2013Philip Hazell, Mohsen Mirzaie
Assessment of randomised controlled trials comparing the efficacy of orally administered tricyclic drugs with placebo in depressed people aged 6 to 18 years found that there was very low-quality evidence for adverse events.
Journal of the American Academy of Child & Adolescent PsychiatryAre Adolescents Changed by an Episode of Major Depression?
241 Citations1994Paul Rohde, Peter M. Lewinsohn +1 more
More scars were found in the present study than in previous research with formerly depressed adults, consistent with the hypothesis that early-onset depression is a more pernicious form of the disorder that may impact adolescents more severely than adults.
Journal of the American Academy of Child & Adolescent PsychiatryA Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression
209 Citations2006Karen Dineen Wagner, Jeffrey M. Jonas +3 more
The data suggest that escitalopram may have beneficial effects in adolescent patients, and the drug appeared to be well tolerated.
PubMedMethods of adolescent suicide prevention.
200 Citations1999D. Shaffer, L Craft
The method of suicide prevention found to be most effective is a systematic, direct-screening procedure that has a high potential for institutionalization.
CNS DrugsAntidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive Disorder
186 Citations2004Robert J. Valuck, Anne M. Libby +3 more
Antidepressant medication use had no statistically significant effect on the likelihood of suicide attempt in a large cohort of adolescents across the US after propensity adjustment for treatment allocation and controlling for other factors.
Journal of Child Psychology and PsychiatryReview of the efficacy and safety of antidepressants in youth depression
183 Citations2005Amy Cheung, Graham J. Emslie +1 more
Clinicians need to be judicious in their interpretation of research data on pediatric antidepressant trials because of the variability in trial methodology and the variation in the drug/placebo response rates within a single trial.
The British Journal of PsychiatryPrevalence of Childhood and Adolescent Depression in the Community
183 Citations1989Jan E. Fleming, David R. Offord +1 more
Utilisation of mental health and social services, comorbidity (combined disorders), poor school performance, problems in getting along with others and need for professional help all increased as diagnostic certainty increased.
Cochrane Database of Systematic ReviewsTricyclic drugs for depression in children and adolescents
171 Citations2002Philip Hazell, Dianne O'Connell +2 more
Data suggest tricyclic antidepressants are not useful in treating depression in pre pubertal children, and there is marginal evidence to support the use of tricyClic antidepressants in the treatment of depression in adolescents.
NeuropsychopharmacologyFrequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports
158 Citations2002Arif Khan, Shirin Khan +3 more
It is suggested that the antidepressant dose schedule may influence trial outcome due in part to a significantly lower magnitude of symptom reduction with placebo in flexible dose trials (F=4.08, df=1, 48, p<0.05) compared to fixed dose trials.
Acta Psychiatrica ScandinavicaSelective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14 857 suicides
154 Citations2005Göran Isacsson, P. Holmgren +1 more
To test the hypothesis that selective serotonin reuptake inhibitor (SSRI) antidepressants may have a suicide emergent effect, particularly in children and adolescents, the aim is to find out if these drugs have an effect on suicide rates.
The Journal of PediatricsFluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial
126 Citations2005Richard M. Glass
Acta Psychiatrica ScandinavicaSuicides are seldom prescribed antidepressants: findings from a prospective prescription database in Jämtland county, Sweden, 1985–95
69 Citations2001S. Henriksson, Göran Boëthius +1 more
Data relating to prospectively monitored treatment and post‐mortem toxicology of individuals who committed suicide are presented.
The Journal of Clinical PsychiatryParoxetine, Other Antidepressants, and Youth Suicide in New York City
67 Citations2004Andrew C. Leon, Peter M. Marzuk +2 more
Despite regulatory concerns, none of the autopsies of youth suicides in New York City detected paroxetine in the victims, although other antidepressants were detected in 4 victims.
Harvard Review of PsychiatryChildhood and Adolescent Depression: A Review
35 Citations1995Caroly Pataki, Gabrielle A. Carlson
Given the significant duration, relapse rate, morbidity, and impaired psychosocial functioning associated with depressive disorders in childhood, further exploration of the natural history and treatment of this condition is warranted.
Archives of General PsychiatryRelationship Between Antidepressant Medication Treatment and Suicide in Adolescents
29 Citations2003Mark Olfson
Journal of Affective DisordersThe effects of extended evaluation on depressive symptoms in children and adolescents
18 Citations1996Jeanne W. Rintelmann
Results suggest that subjects should not be excluded from randomized controlled clinical treatment trials based solely on improvement of symptom severity between visits and an extended evaluation period is warranted, especially for adolescents whose symptom severity tends to fluctuate from week to week.